SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-026290
Filing Date
2024-11-06
Accepted
2024-11-06 21:04:32
Documents
1
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 form4-11072024_021129.html 4  
1 form4-11072024_021129.xml 4 3420
  Complete submission text file 0001415889-24-026290.txt   4901
Mailing Address C/O IDERA PHARMACEUTICALS, INC. 505 EAGLEVIEW BLVD., SUITE 212 EXTON PA 19341
Business Address
Kirby John J. (Reporting) CIK: 0001556327 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38529 | Film No.: 241432780

Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)